Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Invested Capital (2019 - 2026)

Viatris (VTRS) posted Invested Capital of $27.6 billion for Q2 2026, down 4.79% on a QoQ basis from $29.0 billion in Q1 2026, and down 8.09% year-over-year from $30.0 billion in Q2 2025.

Analysis

Viatris (VTRS) Invested Capital (2019 - 2026) Analysis & Trends

Viatris has reported Invested Capital for 8 years, with the latest figure at $27.6 billion in Q2 2026.

  • On a quarterly basis, Invested Capital fell 8.09% year-over-year to $27.6 billion in Q2 2026; TTM through Jun 2026 was $27.6 billion, a 8.09% decrease from a year earlier, with the FY2025 full-year figure at $29.1 billion, down 10.88% from the prior year.
  • Invested Capital was $27.6 billion for Q2 2026 at Viatris, down from $29.0 billion in the prior quarter.
  • The five-year high for Invested Capital was $42.5 billion in Q1 2022, with the low at $27.6 billion in Q2 2026.
  • Average Invested Capital over 5 years is $35.5 billion, with a median of $37.3 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Invested Capital advanced 0.2% in 2023, then decreased 21.45% in 2025.
  • Over 5 years, Invested Capital stood at $40.3 billion in 2022, then fell by 4.33% to $38.6 billion in 2023, then fell by 15.33% to $32.7 billion in 2024, then retreated by 10.88% to $29.1 billion in 2025, then decreased by 5.2% to $27.6 billion in 2026.
  • The last three Invested Capital figures came in at $27.6 billion (Q2 2026), $29.0 billion (Q1 2026), and $29.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 24.35 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 27.61 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 4.90 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 2.70 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 19.84 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 1.15 Bn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 898.70 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.38 Bn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.61 Bn
Mar 31, 2026 29.00 Bn
Dec 31, 2025 29.13 Bn
Sep 30, 2025 29.66 Bn
Jun 30, 2025 30.04 Bn
Mar 31, 2025 29.84 Bn
Dec 31, 2024 32.68 Bn
Sep 30, 2024 35.54 Bn
Jun 30, 2024 36.62 Bn
Mar 31, 2024 37.98 Bn
Dec 31, 2023 38.60 Bn
Sep 30, 2023 39.25 Bn
Jun 30, 2023 39.45 Bn
Mar 31, 2023 39.71 Bn
Dec 31, 2022 40.35 Bn
Sep 30, 2022 39.17 Bn
Jun 30, 2022 41.05 Bn
Mar 31, 2022 42.47 Bn
Dec 31, 2021 43.58 Bn
Sep 30, 2021 44.61 Bn